Among midlife women, only about 21% reached ideal cardiovascular health scores at baseline, per the American Heart ...

In patients with type 2 diabetes and CVD, the GIP/GLP-1 agonist was as good as the older drug, and possibly better in some ...

The company reported revenue of $37.2 million in the first quarter, up 39% year over year, but said it has faced challenges ...

AngioDynamics (Nasdaq:ANGO) announced today that it enrolled the first patient in a randomized study of its Auryon ...

Coronary heart disease is an important source of mortality and morbidity among kidney transplantation and liver transplantation candidates and recipients and is driven by traditional and ...

Impact of prognostic scores on acute kidney injury assessment in the postoperative period of myocardial revascularization ...

On July 15, CMS issued its proposed rule for its 2026 physician fee schedule, that included a 3.6% bump to physician payments. The overall reimbursement for cardiovascular services is projected to ...

AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system.

Perfuze, an Ireland-based developer of catheters for interventional stroke care, recently announced preliminary results from ...

Millipede88 Aspiration Catheter, Perfuze’s Flagship Superbore Aspiration Catheter The trial is evaluating the safety and ...

A joint SCCT/SCAI panel reviewed many opportunities for CT to enhance procedural planning and foster multidisciplinary care.

Five Dogs of the Dow stocks are not only higher on the year but still offer big yields, a degree of safety from tariffs, and ...